Logo image of PRE

PRENETICS GLOBAL LTD-CL A (PRE) Stock Fundamental Analysis

USA - NASDAQ:PRE - KYG722451229 - Common Stock

14.82 USD
+0.67 (+4.73%)
Last: 10/31/2025, 8:08:28 PM
15 USD
+0.18 (+1.21%)
After Hours: 10/31/2025, 8:08:28 PM
Fundamental Rating

3

Taking everything into account, PRE scores 3 out of 10 in our fundamental rating. PRE was compared to 101 industry peers in the Health Care Providers & Services industry. While PRE seems to be doing ok healthwise, there are quite some concerns on its profitability. PRE is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

PRE had negative earnings in the past year.
In the past 5 years PRE always reported negative net income.
In the past 5 years PRE reported 4 times negative operating cash flow.
PRE Yearly Net Income VS EBIT VS OCF VS FCFPRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 0 -50M -100M -150M

1.2 Ratios

PRE has a Return On Assets of -25.50%. This is amonst the worse of the industry: PRE underperforms 83.17% of its industry peers.
PRE has a worse Return On Equity (-31.41%) than 69.31% of its industry peers.
Industry RankSector Rank
ROA -25.5%
ROE -31.41%
ROIC N/A
ROA(3y)-28.89%
ROA(5y)-31.4%
ROE(3y)-37.26%
ROE(5y)-47.44%
ROIC(3y)N/A
ROIC(5y)N/A
PRE Yearly ROA, ROE, ROICPRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 0 -20 -40 -60 -80 -100

1.3 Margins

PRE has a Gross Margin of 42.48%. This is in the better half of the industry: PRE outperforms 70.30% of its industry peers.
PRE's Gross Margin has been stable in the last couple of years.
PRE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 42.48%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
PRE Yearly Profit, Operating, Gross MarginsPRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -100 -200

More info and screens

6

2. Health

2.1 Basic Checks

PRE does not have a ROIC to compare to the WACC, probably because it is not profitable.
PRE has more shares outstanding than it did 1 year ago.
The debt/assets ratio for PRE has been reduced compared to a year ago.
PRE Yearly Shares OutstandingPRE Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
PRE Yearly Total Debt VS Total AssetsPRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 3.20 indicates that PRE is not in any danger for bankruptcy at the moment.
The Altman-Z score of PRE (3.20) is better than 65.35% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that PRE is not too dependend on debt financing.
PRE has a Debt to Equity ratio of 0.00. This is amongst the best in the industry. PRE outperforms 86.14% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 3.2
ROIC/WACCN/A
WACC8.55%
PRE Yearly LT Debt VS Equity VS FCFPRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

PRE has a Current Ratio of 2.37. This indicates that PRE is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of PRE (2.37) is better than 81.19% of its industry peers.
PRE has a Quick Ratio of 2.29. This indicates that PRE is financially healthy and has no problem in meeting its short term obligations.
PRE's Quick ratio of 2.29 is amongst the best of the industry. PRE outperforms 80.20% of its industry peers.
Industry RankSector Rank
Current Ratio 2.37
Quick Ratio 2.29
PRE Yearly Current Assets VS Current LiabilitesPRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 85.17% over the past year.
PRE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -92.12%.
PRE shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -30.65% yearly.
EPS 1Y (TTM)85.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
Revenue 1Y (TTM)-92.12%
Revenue growth 3Y-30.65%
Revenue growth 5YN/A
Sales Q2Q%443.28%

3.2 Future

The Earnings Per Share is expected to grow by 22.61% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 34.15% on average over the next years. This is a very strong growth
EPS Next Y20.64%
EPS Next 2Y17.66%
EPS Next 3Y25.69%
EPS Next 5Y22.61%
Revenue Next Year-56.61%
Revenue Next 2Y10.48%
Revenue Next 3Y35.45%
Revenue Next 5Y34.15%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PRE Yearly Revenue VS EstimatesPRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M 250M
PRE Yearly EPS VS EstimatesPRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -10 -20 -30

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for PRE. In the last year negative earnings were reported.
Also next year PRE is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
PRE Price Earnings VS Forward Price EarningsPRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PRE Per share dataPRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

PRE's earnings are expected to grow with 25.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y17.66%
EPS Next 3Y25.69%

More info and screens

0

5. Dividend

5.1 Amount

PRE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PRENETICS GLOBAL LTD-CL A

NASDAQ:PRE (10/31/2025, 8:08:28 PM)

After market: 15 +0.18 (+1.21%)

14.82

+0.67 (+4.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)09-12 2025-09-12/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners10.13%
Inst Owner Change0%
Ins Owners14.52%
Ins Owner Change0%
Market Cap193.10M
Revenue(TTM)21.74M
Net Income(TTM)-64823600
Analysts80
Price Target26.52 (78.95%)
Short Float %0.33%
Short Ratio0.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-8.43%
Min EPS beat(2)-107.26%
Max EPS beat(2)90.4%
EPS beat(4)1
Avg EPS beat(4)-32.6%
Min EPS beat(4)-107.26%
Max EPS beat(4)90.4%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-71.46%
Min Revenue beat(2)-73.45%
Max Revenue beat(2)-69.46%
Revenue beat(4)0
Avg Revenue beat(4)-62.2%
Min Revenue beat(4)-78.3%
Max Revenue beat(4)-27.58%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)85.71%
PT rev (3m)85.71%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.73
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 1.18
EV/EBITDA N/A
EPS(TTM)-4.68
EYN/A
EPS(NY)-2.59
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS2.59
BVpS15.84
TBVpS12.57
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -25.5%
ROE -31.41%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 42.48%
FCFM N/A
ROA(3y)-28.89%
ROA(5y)-31.4%
ROE(3y)-37.26%
ROE(5y)-47.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.16%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.13
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.37
Quick Ratio 2.29
Altman-Z 3.2
F-ScoreN/A
WACC8.55%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)85.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-100%
EPS Next Y20.64%
EPS Next 2Y17.66%
EPS Next 3Y25.69%
EPS Next 5Y22.61%
Revenue 1Y (TTM)-92.12%
Revenue growth 3Y-30.65%
Revenue growth 5YN/A
Sales Q2Q%443.28%
Revenue Next Year-56.61%
Revenue Next 2Y10.48%
Revenue Next 3Y35.45%
Revenue Next 5Y34.15%
EBIT growth 1Y-19586.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.43%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

PRENETICS GLOBAL LTD-CL A / PRE FAQ

What is the ChartMill fundamental rating of PRENETICS GLOBAL LTD-CL A (PRE) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PRE.


Can you provide the valuation status for PRENETICS GLOBAL LTD-CL A?

ChartMill assigns a valuation rating of 1 / 10 to PRENETICS GLOBAL LTD-CL A (PRE). This can be considered as Overvalued.


Can you provide the profitability details for PRENETICS GLOBAL LTD-CL A?

PRENETICS GLOBAL LTD-CL A (PRE) has a profitability rating of 1 / 10.


Can you provide the financial health for PRE stock?

The financial health rating of PRENETICS GLOBAL LTD-CL A (PRE) is 6 / 10.